Jackson Hole Capital Partners’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Jackson Hole Capital Partners’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-750	Closed	-$49.2K	–	310
2025 Q2	$49.2K	Hold	750	–	–	0.01%	234
2025 Q1	$52.9K	Hold	750	–	–	0.01%	231
2024 Q4	$49.3K	Hold	750	–	–	0.01%	229
2024 Q3	$53K	Hold	750	–	–	0.01%	223
2024 Q2	$49.7K	Hold	750	–	–	0.01%	226
2024 Q1	$50.9K	Hold	750	–	–	0.01%	225
2023 Q4	$46.4K	Hold	750	–	–	0.01%	223
2023 Q3	$44.2K	Hold	750	–	–	0.01%	206
2023 Q2	$44.8K	Hold	750	–	–	0.01%	220
2023 Q1	$43.8K	Hold	750	–	–	0.01%	238
2022 Q4	$46.5K	Hold	750	–	–	0.01%	207
2022 Q3	$42K	Hold	750	–	–	0.01%	204
2022 Q2	$48K	Hold	750	–	–	0.02%	190
2022 Q1	$49K	Hold	750	–	–	0.01%	196
2021 Q4	$50K	Hold	750	–	–	0.02%	191
2021 Q3	$46K	Hold	750	–	–	0.01%	203
2021 Q2	$46K	Hold	750	–	–	0.02%	201
2021 Q1	$44K	Hold	750	–	–	0.02%	197
2020 Q4	$45K	Hold	750	–	–	0.02%	175
2020 Q3	$41K	Hold	750	–	–	0.02%	152
2020 Q2	$38K	Hold	750	–	–	0.02%	140
2020 Q1	$34K	Hold	750	–	–	0.03%	128
2019 Q4	$40K	Hold	750	–	–	0.02%	169
2019 Q3	$35K	Hold	750	–	–	0.02%	167
2019 Q2	$38K	Buy	+750	New	+$37.1K	0.02%	165

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Jackson Hole Capital Partners's IHE Position: Q3 2025 in Review

Jackson Hole Capital Partners sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2025, closing a stake of 750 shares — an estimated $49.2K sold.

Jackson Hole Capital Partners first reported a position in IHE in Q2 2019 and held it in 25 quarters. The position peaked at $53K in Q3 2024. 149 funds tracked by Wall St. Rank hold IHE as of Q3 2025.

Jackson Hole Capital Partners reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2025 after selling out during the quarter.
Jackson Hole Capital Partners sold 750 iShares US Pharmaceuticals ETF shares in Q3 2025, an estimated $49.2K.
Jackson Hole Capital Partners first reported a position in iShares US Pharmaceuticals ETF in Q2 2019 and held it in 25 quarters.
Jackson Hole Capital Partners's iShares US Pharmaceuticals ETF position peaked at $53K in Q3 2024.
149 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2025.

Based on Jackson Hole Capital Partners's 13F filing for Q3 2025, filed 28 Oct 2025.